PROTEOMICS INTERNATIONAL LABORATORIES LIMITED (PIQ)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
PIQ - PROTEOMICS INTERNATIONAL LABORATORIES LIMITED
FNArena Sector :
NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: -0.01
Index:
FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: -0.01
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.05
06 May |
0.000 OPEN $1.05 |
0.000 HIGH $1.05 |
0 LOW $1.05 |
TARGET | |||||
|
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | N/A | - 5.6 | xxx |
DPS (cps) | xxx | N/A | 0.0 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | N/A | xxx |
Dividend Yield | xxx | N/A | 0.0% | xxx |
Div Pay Ratio(%) | xxx | N/A | N/A | xxx |
DIVIDEND YIELD CALCULATOR
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -5.3 |
DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 0.7 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 6.9 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -5.7 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -845.71 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -104.91 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -104.61 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -79.84 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -104.91 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -139.59 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -6.9 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 6 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 12.41 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 1.2 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 166.76 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 8 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 1 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
0.0
No. Of Recommendations
1
PIQ STOCK CHART
FNArena News on PIQ
1 |
Weekly Ratings, Targets, Forecast Changes – 15-03-24Mar 18 2024 - Weekly Reports |
2 |
FNArena Corporate Results Monitor – 28-08-2023Aug 28 2023 - Australia |
3 |
In Brief: Lithium, Telcos, SMAs, HealthcareDec 23 2022 - Weekly Reports |